ES2010231A6 - Metodo para fabricar particulas de proteinas de fusion y metodo para expresar estas proteinas. - Google Patents

Metodo para fabricar particulas de proteinas de fusion y metodo para expresar estas proteinas.

Info

Publication number
ES2010231A6
ES2010231A6 ES878703105A ES8703105A ES2010231A6 ES 2010231 A6 ES2010231 A6 ES 2010231A6 ES 878703105 A ES878703105 A ES 878703105A ES 8703105 A ES8703105 A ES 8703105A ES 2010231 A6 ES2010231 A6 ES 2010231A6
Authority
ES
Spain
Prior art keywords
amino acid
acid sequence
fusion proteins
particles
retrotransposon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES878703105A
Other languages
English (en)
Inventor
Alan J Kingsman
Susan M Kingsman
Sally Elizabeth Adams
Michael H Malim
Mellor Elizabeth-Jane Claire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
Oxford Gene Systems Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626148A external-priority patent/GB8626148D0/en
Priority claimed from GB878708531A external-priority patent/GB8708531D0/en
Priority claimed from US07/036,807 external-priority patent/US5041385A/en
Application filed by Oxford Gene Systems Ltd filed Critical Oxford Gene Systems Ltd
Publication of ES2010231A6 publication Critical patent/ES2010231A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

METODO PARA FABRICAR PARTICULAS DE PROTEINAS DE FUSION Y METODO PARA EXPRESAR ESTAS PROTEINAS. EL METODO DE FABRICACION COMPRENDE TRANSFORMAR CELULAS DE BACTERIAS, LEVADURAS O MAMIFEROS CON UN VECTOR QUE CONTIENE UNA SECUENCIA DE ADN QUE CODIFICA LAS PROTEINAS, HACEN CRECER LAS CELULAS TRANSFORMADAS EN UN MEDIO DE CULTIVO Y AISLAR LAS PARTICULAS FORMADAS, COMPRENDIENDO CADA PROTEINA UNA SECUENCIA DE AMINOACIDOS SUSTANCIALMENTE HOMOLOGA A UNA PROTEINA FORMADORA DE PARTICULAS CODIFICADA POR UN RETROTRANSPOSON O UN RETROVIRUS DE ARN, Y OTRA SECUENCIA DE AMINOACIDOS BIOLOGICAMENTE ACTIVA Y NO FUSIONABLE POR VIA NATURAL CON LA ANTERIOR. EL METODO DE EXPRESION CONSISTE EN TRANSFORMAR CELULAS DE BACTERIAS, LEVADURAS, INSECTOS O MAMIFEROS CON UN VECTOR QUE CONTIENE SECUENCIAS DE NUCLEOTIDOS ADECUADAS, HACER CRECER LAS CELULAS TRANSFORMADAS EN UN MEDIO DE CULTIVO Y AISLAR LA PROTEINA DE FUSION EXPRESADA. EL INVENTO ES UTIL PARA DIAGNOSTICAR Y TRATAR ENFERMEDADES INFECCIOSAS.
ES878703105A 1986-11-01 1987-10-30 Metodo para fabricar particulas de proteinas de fusion y metodo para expresar estas proteinas. Expired ES2010231A6 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868626148A GB8626148D0 (en) 1986-11-01 1986-11-01 Antigen presentation & purification system
GB878708531A GB8708531D0 (en) 1987-04-09 1987-04-09 Fusion proteins & particles
US07/036,807 US5041385A (en) 1986-11-01 1987-04-10 Vector expressing fusion proteins and particles

Publications (1)

Publication Number Publication Date
ES2010231A6 true ES2010231A6 (es) 1989-11-01

Family

ID=27263194

Family Applications (1)

Application Number Title Priority Date Filing Date
ES878703105A Expired ES2010231A6 (es) 1986-11-01 1987-10-30 Metodo para fabricar particulas de proteinas de fusion y metodo para expresar estas proteinas.

Country Status (8)

Country Link
EP (1) EP0330661B1 (es)
JP (2) JP2708046B2 (es)
AU (1) AU606896B2 (es)
CA (1) CA1339263C (es)
DE (1) DE3788807T2 (es)
ES (1) ES2010231A6 (es)
NO (1) NO177793C (es)
WO (1) WO1988003563A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606627B2 (en) * 1986-11-01 1991-02-14 British Bio-Technology Limited Particulate hybrid hiv antigens
US5614404A (en) * 1988-06-10 1997-03-25 Theriod Biologics, Incorporated Self-assembled, defective, non-self-propagating lentivirus particles
US5747324A (en) * 1988-06-10 1998-05-05 Therion Biologics Corporation Self-assembled, defective, non-self-propagating lentivirus particles
US5631154A (en) * 1988-06-10 1997-05-20 Therion Biologics, Incorporated Self assembled, defective, non-self-propagating lentivirus particles
JPH04504950A (ja) * 1988-11-23 1992-09-03 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 位置特異的挿入ベクターおよびこれを用いた方法
JPH04500308A (ja) * 1989-05-17 1992-01-23 リサーチ・コーポレーション・テクノロジーズ・インコーポレーテッド 組換え型生成物のレトロウィルス媒介分泌
WO1990015133A1 (en) * 1989-05-30 1990-12-13 Nippon Zeon Co., Ltd. Method of producing core structure of retro virus and particle produced thereby
WO1990015141A2 (en) * 1989-06-01 1990-12-13 Applied Biotechnology, Inc. Self-assembled, defective, non-self-propagating viral particles
WO1991019803A1 (en) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Self assembled, defective, nonself-propagating viral particles
GB9107631D0 (en) * 1991-04-10 1991-05-29 British Bio Technology Proteinaceous particles
GB9223084D0 (en) * 1992-11-04 1992-12-16 Imp Cancer Res Tech Compounds to target cells
FR2703996B1 (fr) 1993-04-16 1995-07-21 Transgene Sa Ensemble de transposition destine au transfert d'un gene d'interet dans le genome d'une cellule eucaryote.
US20040014033A1 (en) 1999-06-30 2004-01-22 Evotec Biosystems Ag, A Corporation Of Germany Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
US7476517B2 (en) 1999-06-30 2009-01-13 Evotec Ag Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
EP1187928B1 (en) * 1999-06-30 2007-05-23 Evotec AG Virus like particles, preparation and use in screening and functional genomics
EP1219705B1 (en) * 2000-12-29 2007-11-28 Evotec AG Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
FI116198B (fi) 2001-07-16 2005-10-14 Valtion Teknillinen Polypeptidien immobilisointimenetelmä
LT5414B (lt) 2005-04-13 2007-04-25 Biotechnologijos Institutas Monokloninių antikūnų gavimo būdas, hibridomos, gautos šiuo būdu ir rekombinantinės chimerinės į virusus panašios dalelės su įterptais kitų baltymų fragmentais kaip imunogenai hibridomų gavimui šiuo būdu

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
JPS6193199A (ja) * 1984-10-13 1986-05-12 Kyowa Hakko Kogyo Co Ltd 抗インタ−フエロン−γモノクロ−ナル抗体

Also Published As

Publication number Publication date
WO1988003563A1 (en) 1988-05-19
NO882917L (no) 1988-08-29
JPH02501026A (ja) 1990-04-12
EP0330661A1 (en) 1989-09-06
EP0330661B1 (en) 1994-01-12
CA1339263C (en) 1997-08-12
AU606896B2 (en) 1991-02-21
NO177793C (no) 1995-11-22
DE3788807T2 (de) 1994-06-30
NO177793B (no) 1995-08-14
DE3788807D1 (de) 1994-02-24
NO882917D0 (no) 1988-06-30
JP2708046B2 (ja) 1998-02-04
JPH09248191A (ja) 1997-09-22
AU8105787A (en) 1988-06-01

Similar Documents

Publication Publication Date Title
ES2010231A6 (es) Metodo para fabricar particulas de proteinas de fusion y metodo para expresar estas proteinas.
ES2010230A6 (es) Metodo para fabricar particulas de proteinas de fusion con parte de su secuencia homologa a proteinas de hiv y metodo para expresar dichas proteinas.
IE822517L (en) Human immune interferon
ATE93894T1 (de) Expressionssysteme fuer hefe mit pyk-promotoren enthaltenden vektoren und synthese von fremdproteinen.
ATE352559T1 (de) Verfahren zur verminderung der immunogenität von proteinen
DE68929115D1 (de) Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe
EP0328403A3 (en) Synthetic peptides related to the hiv-gp120-env-protein, and their use
GB9227068D0 (en) Novel proteinaceous particles
CA2062969A1 (en) Recombinantly produced human membrane cofactor protein (mcp)
IL87391A0 (en) Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
WO1993018055B1 (en) Peptides stimulating cytotoxic lymphocytes respone to hiv-1 gp160
EP0572737A3 (en) HIV gag-env fusion antigen.
EP0327180A3 (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
DK362088A (da) Fusionsproteiner og fusionsproteinpartikler
GB2336844A (en) Anti-hiv peptides and proteins
AU4712993A (en) New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods
ZA88310B (en) Peptides capable of being recognized by antibodies induced against human immunodeficiency retrovirus(hiv-virus),their applications for diagnosis of infections caused by some of these viruses and,in case,to vaccination against aids
ES2009280A6 (es) Un metodo para detectar anticuerpos al virus hiv-1 en una muestra.

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2007-10-30

PC1A Transfer granted

Owner name: BRITISH BIO-TECHNOLOGY LIMITED